Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic Suppression
CompletedNCT00337467
Bristol-Myers SquibbHuman Immunodeficiency Virus (HIV) Infections
Start: 2006-06-30End: 2009-05-31Updated: 2010-07-19